ATNM
Price
$1.46
Change
-$0.16 (-9.88%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
44.3M
31 days until earnings call
QNRX
Price
$9.27
Change
-$0.46 (-4.73%)
Updated
Jun 27 closing price
Capitalization
5.45M
Interact to see
Advertisement

ATNM vs QNRX

Header iconATNM vs QNRX Comparison
Open Charts ATNM vs QNRXBanner chart's image
Actinium Pharmaceuticals
Price$1.46
Change-$0.16 (-9.88%)
Volume$2.64K
Capitalization44.3M
Quoin Pharmaceuticals
Price$9.27
Change-$0.46 (-4.73%)
Volume$2.56K
Capitalization5.45M
ATNM vs QNRX Comparison Chart in %
Loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNM vs. QNRX commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNM is a Hold and QNRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (ATNM: $1.42 vs. QNRX: $9.27)
Brand notoriety: ATNM and QNRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNM: 961% vs. QNRX: 1%
Market capitalization -- ATNM: $44.3M vs. QNRX: $5.45M
ATNM [@Biotechnology] is valued at $44.3M. QNRX’s [@Biotechnology] market capitalization is $5.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNM’s FA Score shows that 0 FA rating(s) are green whileQNRX’s FA Score has 2 green FA rating(s).

  • ATNM’s FA Score: 0 green, 5 red.
  • QNRX’s FA Score: 2 green, 3 red.
According to our system of comparison, QNRX is a better buy in the long-term than ATNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNM’s TA Score shows that 5 TA indicator(s) are bullish while QNRX’s TA Score has 5 bullish TA indicator(s).

  • ATNM’s TA Score: 5 bullish, 5 bearish.
  • QNRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, QNRX is a better buy in the short-term than ATNM.

Price Growth

ATNM (@Biotechnology) experienced а -5.33% price change this week, while QNRX (@Biotechnology) price change was +6.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

ATNM is expected to report earnings on Jul 28, 2025.

QNRX is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATNM($44.3M) has a higher market cap than QNRX($5.45M). ATNM YTD gains are higher at: 12.698 vs. QNRX (-59.297). QNRX has higher annual earnings (EBITDA): -10.93M vs. ATNM (-48.36M). ATNM has more cash in the bank: 65.3M vs. QNRX (11.6M). ATNM has less debt than QNRX: ATNM (1.43M) vs QNRX (6.21M). ATNM (0) and QNRX (0) have equivalent revenues.
ATNMQNRXATNM / QNRX
Capitalization44.3M5.45M813%
EBITDA-48.36M-10.93M443%
Gain YTD12.698-59.297-21%
P/E RatioN/AN/A-
Revenue00-
Total Cash65.3M11.6M563%
Total Debt1.43M6.21M23%
FUNDAMENTALS RATINGS
ATNM vs QNRX: Fundamental Ratings
ATNM
QNRX
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
6164
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QNRX's Valuation (20) in the Biotechnology industry is somewhat better than the same rating for ATNM (73). This means that QNRX’s stock grew somewhat faster than ATNM’s over the last 12 months.

QNRX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ATNM (100). This means that QNRX’s stock grew similarly to ATNM’s over the last 12 months.

QNRX's SMR Rating (99) in the Biotechnology industry is in the same range as ATNM (99). This means that QNRX’s stock grew similarly to ATNM’s over the last 12 months.

ATNM's Price Growth Rating (61) in the Biotechnology industry is in the same range as QNRX (64). This means that ATNM’s stock grew similarly to QNRX’s over the last 12 months.

QNRX's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for ATNM (100). This means that QNRX’s stock grew significantly faster than ATNM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATNMQNRX
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
73%
Bullish Trend 3 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADD0.910.08
+9.18%
Color Star Technology Co Ltd
LZ8.840.19
+2.20%
LegalZoom.com
EQH55.96-0.06
-0.11%
Equitable Holdings
ABUS3.12-0.07
-2.34%
Arbutus Biopharma Corp
MSPR1.21-0.05
-3.97%
MSP Recovery Inc

ATNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with GBIO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNM
1D Price
Change %
ATNM100%
-12.35%
GBIO - ATNM
47%
Loosely correlated
-5.63%
IMNM - ATNM
37%
Loosely correlated
-0.11%
HOWL - ATNM
35%
Loosely correlated
-12.55%
PRLD - ATNM
34%
Loosely correlated
-4.64%
IDYA - ATNM
34%
Loosely correlated
-4.04%
More